Published in Environ Pollut on January 01, 1989
Lac repressor-operator interaction. I. Equilibrium studies. J Mol Biol (1970) 13.32
The lac repressor-operator interaction. 3. Kinetic studies. J Mol Biol (1970) 10.07
DNA binding of the lac repressor. J Mol Biol (1968) 5.02
lac Repressor-operator interaction. VI. The natural inducer of the lac operon. J Mol Biol (1972) 3.06
On the assay, isolation and characterization of the lac repressor. J Mol Biol (1968) 2.94
"Second" and "third operator" of the lac operon: an investigation of their role in the regulatory mechanism. J Mol Biol (1979) 2.56
lac repressor--operator interaction. II. Effect of galactosides and other ligands. J Mol Biol (1970) 2.42
Suppression of and complementation among mutants of the regulatory gene of the lactose operon of Escherichia coli. J Mol Biol (1965) 2.32
lac Repressor-operator interaction. IX. The binding of lac repressor to operators containing Oc mutations. J Mol Biol (1974) 2.31
A low-copy-number vector utilizing beta-galactosidase for the analysis of gene control elements. Gene (1987) 2.30
Cloning and analysis of the promotor region of the human fibronectin gene. Proc Natl Acad Sci U S A (1987) 2.10
Lac repressor-operator interaction. V. Characterization of super- and pseudo-wild-type repressors. J Mol Biol (1972) 2.02
Measurements of unwinding of lac operator by repressor. Nature (1974) 1.98
Ethiopia: between Sub-Saharan Africa and western Eurasia. Ann Hum Genet (2005) 1.98
The lac repressor-operator interaction. VII. A repressor with unique binding properties: the X86 repressor. J Mol Biol (1972) 1.78
The lac repressor-operator interaction. IV. Assay and purification of operator DNA. Biochem Biophys Res Commun (1970) 1.75
Regulation of fibronectin biosynthesis by dexamethasone, transforming growth factor beta, and cAMP in human cell lines. J Cell Biol (1988) 1.61
Repressors. Adv Protein Chem (1976) 1.51
FKBP51, a novel T-cell-specific immunophilin capable of calcineurin inhibition. Mol Cell Biol (1995) 1.45
Regulation of fibronectin biosynthesis by glucocorticoids in human fibrosarcoma cells and normal fibroblasts. Cell (1983) 1.42
Composite predictions of secondary structures of lac repressor. Biopolymers (1979) 1.31
Isolation and characterization of glucocorticoid- and cyclic AMP-induced genes in T lymphocytes. Mol Cell Biol (1989) 1.31
Tissue distribution and abundance of human FKBP51, and FK506-binding protein that can mediate calcineurin inhibition. Biochem Biophys Res Commun (1997) 1.30
DNA binding properties of glucocorticosteroid receptors bound to the steroid antagonist RU-486. EMBO J (1984) 1.27
Diploid and haploid states of the glucocorticoid receptor gene of mouse lymphoid cell lines. Cell (1977) 1.23
Demethylation and expression of murine mammary tumor proviruses in mouse thymoma cell lines. Proc Natl Acad Sci U S A (1983) 1.23
Forskolin inducibility and tissue-specific expression of the fibronectin promoter. Mol Cell Biol (1989) 1.19
General features of steroid resistance on lymphoid cell lines. Mol Cell Endocrinol (1978) 1.16
Analysis of the cya locus of Escherichia coli. Gene (1984) 1.16
Role of de novo DNA methylation in the glucocorticoid resistance of a T-lymphoid cell line. Nature (1983) 1.16
Lac repressor-operator interaction. 8. Lactose is an anti-inducer of the lac operon. J Mol Biol (1973) 1.07
Phenotype of autosomal dominant spastic paraplegia linked to chromosome 2. Brain (1996) 1.06
Correlation between glucocorticoid receptor and cytolytic response of murine lymphoid cell lines. Cancer Res (1979) 1.04
A new determinant of glucocorticoid sensitivity in lymphoid cell lines. J Cell Biol (1983) 1.02
Genes newly identified as regulated by glucocorticoids in murine thymocytes. Mol Endocrinol (1991) 1.01
Interaction of glucocorticoid receptors from lymphoid cell lines with their nuclear acceptor sites. Mol Cell Endocrinol (1978) 0.99
Cyclic AMP-dependent protein kinase promotes glucocorticoid receptor function. J Biol Chem (1986) 0.99
Genetically engineered zinc-chelating adenylate kinase from Escherichia coli with enhanced thermal stability. J Biol Chem (1998) 0.98
Identification of a gene induced by glucocorticoids in murine T-cells: a potential G protein-coupled receptor. Mol Endocrinol (1991) 0.96
A new murine model system for the in vitro development of thymoma cell heterogeneity. Cancer Res (1984) 0.96
Characterization of a new type of thymoma variants supersensitive to dexamethasone. J Steroid Biochem (1981) 0.91
Defect states at the TiO2(110) surface probed by resonant photoelectron diffraction. Phys Rev Lett (2008) 0.90
Glucorticoid resistance in murine lymphoma and thymoma lines. Cancer Res (1978) 0.88
Two outbreaks of botulism associated with consumption of green olive paste, France, September 2011. Euro Surveill (2011) 0.88
Isolation of pseudorevertants of lac oc mutants: selection system for superoperator mutations. J Bacteriol (1976) 0.87
Analysis of steroid resistance in lymphoid cell hybrids. Somatic Cell Genet (1980) 0.86
Cyclic AMP-dependent protein kinase modulation of the glucocorticoid-induced cytolytic response in murine T-lymphoma cells. Mol Endocrinol (1989) 0.86
Intrinsic nature of the excess electron distribution at the TiO2(110) surface. Phys Rev Lett (2012) 0.85
Reversal of multidrug resistance by RU 486. Cancer Res (1994) 0.85
A novel mechanism of Ha-ras oncogene action: regulation of fibronectin mRNA levels by a nuclear posttranscriptional event. Mol Cell Biol (1994) 0.85
Induction of glucocorticoid-resistant variants in a murine thymoma line by antitumor drugs. Cancer Res (1981) 0.83
Posttranscriptional down-regulation of fibronectin in N-ras-transformed cells. Cell Growth Differ (1991) 0.82
Differential activity of dexamethasone on IL-2-, IL-4-, or IL-9-induced proliferation of murine factor-dependent T cell lines. J Immunol (1996) 0.82
Specific binding of the cAMP receptor protein of Escherichia coli to the lactose operon promoter. Biochimie (1985) 0.81
Glucocorticoid receptors in human leukemias and related diseases. Klin Wochenschr (1985) 0.79
Structure and deformations of Pd-Ni core-shell nanoparticles. J Phys Chem B (2005) 0.79
Chemosensitizing steroids: glucocorticoid receptor agonists capable of inhibiting P-glycoprotein function. Cancer Res (1997) 0.79
Tcl-30, a new T cell-specific gene expressed in immature glucocorticoid-sensitive thymocytes. J Immunol (1992) 0.79
Membrane permeability as a determinant of dexamethasone resistance in murine thymoma cells. Cancer Res (1984) 0.78
Glucocorticoid-induced lymphocytolysis: state of the genetic analysis. J Supramol Struct (1980) 0.78
Expression of the mdr1 P-glycoprotein gene: a mechanism of escape from glucocorticoid-induced apoptosis. Biochem Cell Biol (1995) 0.78
Guidelines for the management of chronic hepatitis C in patients infected after substance use. Acta Gastroenterol Belg (2005) 0.77
Isolation of new types of dexamethasone-resistant variants from a cAMP-resistant lymphoma. J Steroid Biochem (1986) 0.76
A nuclear post-transcriptional mechanism mediates the induction of fibronectin by glucocorticoids. Mol Cell Endocrinol (1995) 0.76
Fatal Yersinia enterocolitica transfusion reaction. J Clin Pathol (1997) 0.75
Hepatic myelopathy. Neurology (1993) 0.75
Mitigating the burden of hepatitis C virus among people who inject drugs in Belgium. Acta Gastroenterol Belg (2016) 0.75
Characterization of the glucocorticoid receptor. Comparison of wild type and variant receptors. J Biol Chem (1984) 0.75
Changes in lipids and sterols during composting. J Environ Sci Health B (2001) 0.75
Mucoadhesion evaluation of polysaccharide gels for vaginal application by using rheological and indentation measurements. Colloids Surf B Biointerfaces (2011) 0.75
[Contribution to the study of blood changes associated with leg ulcers]. Phlebologie (1965) 0.75
Influence of soluble organic matter on cadmium mobility in model compounds and in soils. Analyst (1992) 0.75
Skin absorption studies of octyl-methoxycinnamate loaded poly(D,L-lactide) nanoparticles: estimation of the UV filter distribution and release behaviour in skin layers. J Microencapsul (2010) 0.75
Quadrupolar transitions evidenced by resonant auger spectroscopy. Phys Rev Lett (2002) 0.75
High-resolution anion exchange chromatography of the glucocorticoid receptor from WEHI-7 cells. J Steroid Biochem (1988) 0.75
Characteristics, treatment, and virologic responses of chronic hepatitis C patients treated with peginterferon alfa-2a and ribavirin in belgium: a sub-analysis of the PROPHESYS study. Acta Gastroenterol Belg (2014) 0.75
Hydroliquefaction of green wastes to produce fuels. Bioresour Technol (2011) 0.75
[Dysorthography and anxiety]. Rev Neuropsychiatr Infant (1975) 0.75
A non-interventional phase IV Belgian survey to assess the antiviral effectiveness of pegylated interferon-alpha-2b and ribavirin treatment according to the stage of liver fibrosis in previously untreated patients with genotype 1/4/5/6 chronic hepatitis C (PRACTICE). Acta Gastroenterol Belg (2014) 0.75
Elaboration and characterization of barium silicate thin films. Micron (2008) 0.75
Ascaris lumbricoides. JBR-BTR (2002) 0.75
Methods for studying protein-nucleic acid interaction. Acta Endocrinol Suppl (Copenh) (1972) 0.75
Improvement of an encapsulation process for the preparation of pro- and prebiotics-loaded bioadhesive microparticles by using experimental design. Eur J Pharm Sci (2011) 0.75
[Migrating phlebitis with hypogammaglobulinemia]. Phlebologie (1965) 0.75
Gastrointestinal arterial fibromuscular dysplasia of childhood. Arch Pathol Lab Med (1988) 0.75
Kidney cortex cells derived from SV40 transgenic mice retain intrinsic properties of polarized proximal tubule cells. Kidney Int (1999) 0.75
Achieving WHO recommendations for Hepatitis C Virus Elimination in Belgium. Acta Gastroenterol Belg (2016) 0.75
[Varicosities. Clinical and therapeutic aspects]. Phlebologie (1965) 0.75
Nuclear interactions of wild type and variant glucocorticoid receptors. J Steroid Biochem (1984) 0.75
[Clinical effects, therapeutic indications and posology of synthetic heparinoid 8.061 CB]. Phlebologie (1968) 0.75